company background image
DPH logo

Dechra Pharmaceuticals LSE:DPH Voorraadrapport

Laatste prijs

UK£38.66

Marktkapitalisatie

UK£4.4b

7D

0.2%

1Y

32.4%

Bijgewerkt

16 Jan, 2024

Gegevens

Financiële gegevens bedrijf +

Dechra Pharmaceuticals PLC

LSE:DPH Voorraadrapport

Marktkapitalisatie: UK£4.4b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

DPH Overzicht aandelen

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians.

Over het bedrijf

Beloningen

De winst zal naar verwachting met 62.48% per jaar groeien

Risicoanalyse

Rentebetalingen worden niet goed gedekt door de winsten

Dechra Pharmaceuticals PLC Concurrenten

Hikma Pharmaceuticals

LSE:HIK

UK£4.2b

HUTCHMED (China)

AIM:HCM

UK£2.6b

Indivior

LSE:INDV

UK£1.0b

GSK

LSE:GSK

UK£59.5b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Dechra Pharmaceuticals
Historische aandelenkoersen
Huidige aandelenkoersUK£38.66
52 Week HoogtepuntUK£41.46
52 Week LaagUK£24.73
Bèta0.78
11 maand verandering0.68%
3 maanden verandering1.84%
1 Jaar Verandering32.40%
33 jaar verandering5.57%
5 jaar verandering60.15%
Verandering sinds IPO2,828.79%

Recent nieuws en updates

Recent updates

Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

May 31
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt

A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Mar 28
A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Mar 02
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt

Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Mar 02
Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dec 09
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Oct 06
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289

Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Sep 22
Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Sep 08
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289

Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Aug 18
Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

Aug 02
Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?

These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Jun 10
These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well

Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

May 08
Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)

Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Apr 22
Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?

Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Feb 23
Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12

Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 29
Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value

Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Jan 11
Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?

Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

Dec 04
Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly

It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Oct 15
It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package

Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Sep 25
Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's

Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

Sep 11
Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29

With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Sep 08
With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting

Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Jun 17
Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?

Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Apr 09
Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?

Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Mar 05
Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet

Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 17
Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Feb 02
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Rendement voor aandeelhouders

DPHGB PharmaceuticalsGB Markt
7D0.2%-0.7%-0.8%
1Y32.4%4.5%9.2%

Rendement versus industrie: DPH overtrof de UK Pharmaceuticals industrie, die het afgelopen jaar een rendement 6.4 % opleverde.

Rendement versus markt: DPH overtrof de UK markt, die het afgelopen jaar een rendement opleverde van 9.7 %.

Prijsvolatiliteit

Is DPH's price volatile compared to industry and market?
DPH volatility
DPH Average Weekly Movement0.5%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.4%
10% least volatile stocks in GB Market2.6%

Stabiele aandelenkoers: DPH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van DPH is het afgelopen jaar gedaald van 6% naar 0%.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19972,457Ian Pagewww.dechra.com

Dechra Pharmaceuticals PLC Samenvatting

Hoe verhouden de winst en inkomsten van Dechra Pharmaceuticals zich tot de beurswaarde?
DPH fundamentele statistieken
MarktkapitalisatieUK£4.40b
Inkomsten(TTM)-UK£27.90m
Inkomsten(TTM)UK£761.50m

5.8x

P/S-verhouding

-157.8x

Koers/Winstverhouding

Is DPH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
DPH resultatenrekening (TTM)
InkomstenUK£761.50m
Kosten van inkomstenUK£331.90m
BrutowinstUK£429.60m
Overige uitgavenUK£457.50m
Inkomsten-UK£27.90m

Laatst gerapporteerde inkomsten

Jun 30, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-0.24
Brutomarge56.42%
Nettowinstmarge-3.66%
Schuld/Eigen Vermogen Verhouding64.6%

Hoe presteerde DPH op de lange termijn?

Bekijk historische prestaties en vergelijking